Haematologica (Jan 2007)

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen

  • Arne Kolstad,
  • Harald Holte,
  • Alexander Fosså,
  • Grete Fossum Lauritzsen,
  • Peter Gaustad,
  • Dag Torfoss

DOI
https://doi.org/10.3324/haematol.10564
Journal volume & issue
Vol. 92, no. 1

Abstract

Read online

We report six cases of Pneumocystis jirovecii pneumonia (PCP) verified by immunoflourescence/polymerase chain reaction of bronchoalveolar fluid among 46 lymphoma patients (13%) who received rituximab-CHOEP-14 at our institution. PCP prophylaxis should be standard management for this group of patients and also considered for patients treated with rituximab-CHOP-14, CHOP-14 or CHOEP-14.